Peptide Initiative
Back to CJC-1295 with DAC

Clinical trials

Every registered trial of CJC-1295 with DAC

1 study.

Plain-Language Summary

Plain-language reading of the public trial registries.

In short

  • Very little human research on CJC-1295 with DAC has been registered.
  • 1 registered study in total.
  • None are currently enrolling — this research has already happened.

What kind of research

  • 1 study actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
  • About 120 people took part in those.

A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.

Filter

Showing 1 of 1 trial for CJC-1295 with DAC.

  • NCT00267527 Phase 2Terminated120 enrolled2005

    A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity

    ConjuChem

    Obesity · HIV Infections

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when CJC-1295 with DAC is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.